Lumos Diagnostics Holdings Ltd - Asset Resilience Ratio

Latest as of December 2025: 14.18%

Lumos Diagnostics Holdings Ltd (LDX) has an Asset Resilience Ratio of 14.18% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check LDX strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$2.99 Million

≈ $2.12 Million USD Cash + Short-term Investments

Total Assets

AU$21.12 Million

≈ $14.94 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Lumos Diagnostics Holdings Ltd's Asset Resilience Ratio has changed over time. See Lumos Diagnostics Holdings Ltd (LDX) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Lumos Diagnostics Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Lumos Diagnostics Holdings Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$2.99 Million	14.18%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$2.99 Million	14.18%

Asset Resilience Insights

Moderate Liquidity: Lumos Diagnostics Holdings Ltd has 14.18% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Lumos Diagnostics Holdings Ltd Industry Peers by Asset Resilience Ratio

Compare Lumos Diagnostics Holdings Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
MicroPort Endovascular MedTech Ltd SHG:688016	Medical Devices	20.69%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	Medical Devices	2.82%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A SHG:688212	Medical Devices	6.09%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%

Annual Asset Resilience Ratio for Lumos Diagnostics Holdings Ltd (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Lumos Diagnostics Holdings Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.40%	AU$1.96 Million ≈ $1.38 Million	AU$20.81 Million ≈ $14.73 Million	-14.74pp
2023-12-31	24.14%	AU$6.48 Million ≈ $4.58 Million	AU$26.84 Million ≈ $18.99 Million	+12.28pp
2022-12-31	11.86%	AU$3.02 Million ≈ $2.13 Million	AU$25.42 Million ≈ $17.99 Million	-9.74pp
2021-12-31	21.60%	AU$7.98 Million ≈ $5.64 Million	AU$36.94 Million ≈ $26.14 Million	-24.21pp
2020-12-31	45.81%	AU$44.89 Million ≈ $31.76 Million	AU$97.99 Million ≈ $69.33 Million	+43.00pp
2019-12-31	2.81%	AU$850.30K ≈ $601.64K	AU$30.28 Million ≈ $21.42 Million	-9.05pp
2018-12-31	11.86%	AU$3.01 Million ≈ $2.13 Million	AU$25.40 Million ≈ $17.97 Million	+9.31pp
2017-12-31	2.55%	AU$226.43K ≈ $160.21K	AU$8.89 Million ≈ $6.29 Million	--

pp = percentage points

About Lumos Diagnostics Holdings Ltd

AU:LDX Australia Medical Devices

Market Cap

$68.64 Million

AU$97.01 Million AUD

Market Cap Rank

#20623 Global

#699 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.32

All Time High

AU$1.22